Gordon Okawara

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

Bruce D. Minsky, Thomas F. Pajak, Robert J. Ginsberg et al. · Journal of Clinical Oncology · 2002 · 1.1K citations

Medicine, Oncology, Radiation Oncology +17

Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response

Jaffer A. Ajani, Kathryn Winter, Gordon Okawara et al. · Journal of Clinical Oncology · 2006 · 385 citations

Medicine, Oncology, Surgery +17

Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer

Scott M. Lippman, Daniel D. Karp, Everett E. Vokes et al. · JNCI Journal of the National Cancer Institute · 2001 · 319 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non–Small-Cell Lung Cancer: ECOG 5597

Daniel D. Karp, Sandra J. Lee, Steven M. Keller et al. · Journal of Clinical Oncology · 2013 · 129 citations · Full text

Medicine, Oncology, Pharmacology +14

Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer

Theodoros Tsakiridis, Gregory R. Pond, Naseer Ahmed et al. · JAMA Oncology · 2021 · 109 citations · Full text

Medicine, Oncology, Pharmacotherapy +16